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Accepted 26 July 2011Fetal pleural effusion refers to an accumulation of fluid in
the pleural space. It is most commonly attributed postnatally to
chylothorax, a primary lymphatic abnormality. Following the
diagnosis of pleural effusion, detailed investigation is essential
to exclude other conditions (secondary pleural effusion). The
natural history of the lesion is variable. The effusion may
resolve spontaneously, remain stable or progress to hydrops
and fetal or neonatal demise [1]. The treatment modalities
include thoracocentesis, pleuro-amniotic shunting and pleu-
rodesis. The optimal antenatal management is controversial
[2,3]. We report a case of isolated pleural effusion diagnosed
at 32 weeks of gestation that we successfully treated with
thoracocentesis, resulting in a good outcome.
The patient was a 30-year-old woman, G2P1A0, referred to
our hospital for further management of fetal right pleural
effusion at 32 weeks’ gestation. According to the referral
information, the pregnancy had been unremarkable until 32
weeks’ gestation. She had not had any illness or recent
infectious disease, had not been exposed to teratogenic agents
during the pregnancy, and did not have a family history of
congenital anomalies. The Down syndrome screen during her
second trimester was negative. She had a history of previous
cesarean section as a result of preeclampsia and fetal distress.
Sonography demonstrated fetal right pleural effusion
(Fig. 1). The right lung was compressed and displaced slightly
to the midline. There was no evidence of pericardial effusion
or gross cardiac defect. There was no other fetal anomaly
detectable during the detailed ultrasound examination. One
week after the initial visit to our hospital, an increase in the
volume of the fetal right pleural effusion occurred. Trans-
abdominal fetal thoracocentesis at 33 2/7 weeks’ gestation
was suggested and the patient consented to undergo the
procedure. Using a 22-gauge needle and sonographic guid-
ance, 70 mL yellow fluid was removed from the right fetal* Corresponding author. Department of Obstetrics and Gynecology, Kaoh-
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Repeated ultrasound scans over the course of the next few
days showed an increasing volume of pleural fluid accumu-
lation, with a mediastinal shift of the right lung. At 34 weeks’
gestation, pericardial effusion, cardiomegaly and subcuta-
neous edema occurred. Hydrops was suspected and the
mediastinal shift of the right lung progressed. Prompt delivery
of the fetus was suggested. Thoracocentesis was performed
prior to the cesarean delivery and 150 ml of pleural fluid was
removed. A female infant weighting 2300 g was delivered,
with Apgar scores of 4 and 8 at 1 and 5 minutes, respectively.
The infant was born in relatively good condition. She
breathed spontaneously and was transferred to the neonatal
intensive care unit. Nonetheless, because of cyanosis with
chest retraction, she required intubation and ventilation shortly
after birth. A chest X-ray revealed massive right pleural
effusion. A chest tube was inserted a few hours after delivery.
Biochemical analyses of the pleural fluid (triglycerides:
747 mg/dL; lymphocyte proportion: 92%) confirmed the
diagnosis of chylothorax. The infant was extubated on Day 3.
The pleural effusion volume decreased gradually. The chest
tube was removed on Day 13. The infant received conservative
management and was discharged 28 days after birth. Subse-
quent follow-up showed normal growth and development.
Fetal pleural effusion is a rare condition. The incidence is
estimated to be 1/10,000 to 1/15,000 pregnancies [4]. Primary
pleural effusions are caused by lymphatic leakage and can be
unilateral or bilateral [3]. In a recent study, the survival rate of
primary pleural effusion without intrauterine treatment was
59% (35% with hydrops and 73% without hydrops) [2]. The
optimal management of fetal pleural effusion in the prenatal
period is still a matter of debate.
Observation is appropriate in the case of primary, small,
nonhydropic effusions, because spontaneous regression can
occur [1,3]. Klam et al. suggested that conservative manage-
ment is the preferred management option in most cases of
primary fetal hydrothorax [5]. However, Knox et al. showed
that prenatal intrauterine drainage did not improve perinatal
survival compared with no drainage, except in fetuses withcs & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
Fig. 1. Sonogram of fetus at 32 weeks of gestation showing right pleural
effusion.
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prenatal intervention should be offered [2]. Recent research
supports the notion that in utero intervention improves the
survival of fetuses with persistent effusions and hydrops [2,7].
The treatment options include repeated thoracocentesis,
thoraco-amniotic shunting, and pleurodesis. Although there are
no statistically significant differences between the treatments
[2,7], thoraco-amniotic shunting appears superior to other
treatments [2,3]. Thoraco-amniotic shunting is a more invasive
procedure and may not available in every hospital. Catheter
migration, obstruction, preterm premature rupture of amniotic
membrane, and chorioamnionitis are the main complications
[3]. Pleurodesis is a new form of prenatal treatment of fetal
hydrothorax, which is achieved by intrapleural injection of OK-
432, a sclerosing agent. Data on this new procedure are limited
[2,3]. Further studies are needed to clarify the role of this
therapy for treatment of fetal hydrothorax.
Pleural effusions sometimes resolve in utero after thor-
acocentesis [8,9]. However, recurrence of the pleural effusion
occurs in the majority of cases [1,5,7]. If recurrence of pleura
fluid accumulation ensues, repeat thoracocentesis may be
considered. However, repeat thoracocentesis could cause
hypoproteinemia, which favors the development of hydrops
[1,3]. Thoracocentesis may be performed before delivery and
seems to facilitate neonatal resuscitation [10]. It allows
newborns to breathe spontaneously, be more easily ventilated,
and reduces emergency chest tube insertion [11].
Premature delivery and the presence of hydrops consis-
tently are regarded as the most important poor prognostic
indicators of fetal hydrothorax [3]. Gestational age is animportant factor in deciding treatment [7]. Aubard et al. sug-
gested that before 32 weeks of gestation, the greatest fetal
survival can be obtained by placement of a pleuro-amniotic
shunt. Between 32 and 37 weeks, thoracocentesis provides
the best results [1].
Primary fetal pleural effusion is a rare pathology in which
antenatal therapeutic approaches range from simply observing
to performing highly invasive in utero interventions. From our
experience in treating this case and researching the literature,
we decided to proceed conservatively at first, with close
follow-up. Then, if intervention was necessary, thoracocent-
esis should be the initial treatment modality of fetal pleural
effusion because resolution could occur. If the pleural effusion
recurred, close monitoring with ultrasound was suggested. If
the pleural effusion progressed quickly or hydrops developed,
the next step of treatment should be based on the gestational
age of the fetus. When the gestational age is 32e34 weeks,
prompt delivery should be suggested. When the gestational
age is less than 32 weeks, thoraco-amniotic shunting should be
considered. We also recommended thoracocentesis prior to
delivery to facilitate neonatal resuscitation.
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